Congratulations, your medical device is a success! But don’t celebrate yet—patent litigation may be next (objectively speaking). Patents are a strategic asset in medtech, where proprietary innovation is key to
Continue Reading How Smart Business Leaders Prepare for a Patent Fight
Medical device manufacturers face mounting pressure to deliver innovative products while reducing costs and improving margins. To meet these challenges, many original equipment manufacturers (OEMs) outsource critical operations such as
Continue Reading Building Strong Medtech Partnerships: Keys to Successful Contract Manufacturing Agreements
After several years of volatility and unfavorable market dynamics, the initial public offering (IPO) market for medical technology companies is beginning to reopen meaningfully. Following the most recent IPO boom
Continue Reading From Innovation to IPO: A Strategic Checklist for Medtech Companies
The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging
Continue Reading Building a Future-Proof IP Strategy for AI in Medtech
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their
Continue Reading Why Patent Portfolios are Crucial for Life Science Innovators
U.S. life sciences companies with ties overseas can be encouraged by a recent federal ruling that denied the request of foreign companies to conduct discovery in the United States in
Continue Reading Federal Court Denies Request of Foreign Companies to Conduct Discovery in the United States in Aid of a Foreign-Seated Arbitration
Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life
Continue Reading Tel Aviv Office to Host Capital Markets Roundtable for the Life Sciences Industry
Economics in getting a compound approved and commercialized are evolving. Drug companies have reduced budgets that historically funded vast R&D teams. Innovators are chasing tight investment dollars. The two camps
Continue Reading How Big Pharma Taps Outside Ingenuity
Greenberg Traurig will be sponsoring two major Israel events this coming week.
The first is the OurCrowd Global Investor Summit (January 25-26), set to bring together 3,000 investors and companies
Continue Reading Greenberg Traurig to Sponsor Two Major Israel Event